FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143149098> ?p ?o ?g. }

• W2143149098 endingPage "111" @default.
• W2143149098 startingPage "104" @default.
• W2143149098 abstract "It has been established that smoking is an important risk factor for the initiation and progression of chronic periodontitis (CP). This study investigates the effects of phase I periodontal therapy and adjunctive flurbiprofen administration on prostaglandin E(2) (PGE(2)) and thiobarbituric acid reactive substance (TBARS) levels in gingival crevicular fluid (GCF) samples from smoker and non-smoker patients with CP.Twenty-one non-smoker and 21 smoker patients with CP were divided into four groups according to treatment modalities. Group 1 (non-smokers with CP) and group 3 (smokers with CP) patients received daily 100-mg flurbiprofen tablets in a 2 x 1 regimen for 10 days together with scaling and root planing (SRP). Patients in group 2 (non-smokers with CP) and group 4 (smokers with CP) received placebo tablets in a 2 x 1 regimen for 10 days together with SRP. Plaque index (PI), gingival index (GI), probing depth (PD), and clinical attachment level (CAL) measurements were recorded and GCF samples were collected at baseline and on day 10 of drug intake from each sampling area by a single examiner who was unaware of the treatment modality. Assays for GCF PGE(2) and TBARS were carried out by an enzyme-linked immunosorbent assay and fluorometric method, respectively.All groups showed statistically significant reductions in PI and GI scores following the phase I periodontal treatment on day 10 (P <0.05), but no statistical differences were observed in PD and CAL scores after the therapy. In groups 1 and 2, the reduction of GCF PGE(2) and TBARS levels were not significant after the therapy compared to baseline levels. In group 3, GCF PGE(2) and TBARS levels exhibited a statistically significant decrease (P <0.05) after the therapy. Group 4 showed significant reductions (P <0.05) in GCF PGE(2) levels after the therapy. No statistically significant reductions were observed in group 4 with regard to GCF TBARS levels. When groups 1 and 3 were compared according to GCF TBARS levels after the therapy, a more statistically significant reduction was observed in group 3 (P = 0.001).These results suggest that additional flurbiprofen administration may have more inhibitory effects on GCF levels of PGE(2) and TBARS in the groups of smokers compared to non-smokers with CP." @default.
• W2143149098 created "2016-06-24" @default.
• W2143149098 creator A5005082406 @default.
• W2143149098 creator A5026127979 @default.
• W2143149098 creator A5029565955 @default.
• W2143149098 creator A5030424347 @default.
• W2143149098 creator A5030839291 @default.
• W2143149098 creator A5083361918 @default.
• W2143149098 date "2007-01-01" @default.
• W2143149098 modified "2023-09-23" @default.
• W2143149098 title "Gingival Crevicular Fluid Prostaglandin E₂and Thiobarbituric Acid Reactive Substance Levels in Smokers and Non-Smokers With Chronic Periodontitis Following Phase I Periodontal Therapy and Adjunctive Use of Flurbiprofen" @default.
• W2143149098 cites W1968400023 @default.
• W2143149098 cites W1970591947 @default.
• W2143149098 cites W1975161268 @default.
• W2143149098 cites W1982762170 @default.
• W2143149098 cites W1983759074 @default.
• W2143149098 cites W1986786856 @default.
• W2143149098 cites W1987219098 @default.
• W2143149098 cites W1991368838 @default.
• W2143149098 cites W1991783650 @default.
• W2143149098 cites W2003351283 @default.
• W2143149098 cites W2003421878 @default.
• W2143149098 cites W2023862388 @default.
• W2143149098 cites W2044756678 @default.
• W2143149098 cites W2047550846 @default.
• W2143149098 cites W2055097867 @default.
• W2143149098 cites W2057782747 @default.
• W2143149098 cites W2064599448 @default.
• W2143149098 cites W2071979542 @default.
• W2143149098 cites W2072274141 @default.
• W2143149098 cites W2073011395 @default.
• W2143149098 cites W2073736083 @default.
• W2143149098 cites W2075867863 @default.
• W2143149098 cites W2078488789 @default.
• W2143149098 cites W2078668545 @default.
• W2143149098 cites W2087476378 @default.
• W2143149098 cites W2088762255 @default.
• W2143149098 cites W2107228383 @default.
• W2143149098 cites W2108882908 @default.
• W2143149098 cites W2122430375 @default.
• W2143149098 cites W2122841504 @default.
• W2143149098 cites W2132253648 @default.
• W2143149098 cites W2132517530 @default.
• W2143149098 cites W2134750347 @default.
• W2143149098 cites W2135699493 @default.
• W2143149098 cites W2142952677 @default.
• W2143149098 cites W2144610619 @default.
• W2143149098 cites W2158871306 @default.
• W2143149098 cites W2160740465 @default.
• W2143149098 cites W2164405794 @default.
• W2143149098 cites W2164517553 @default.
• W2143149098 cites W2165059229 @default.
• W2143149098 cites W2166718335 @default.
• W2143149098 cites W2168666458 @default.
• W2143149098 cites W2219107687 @default.
• W2143149098 doi "https://doi.org/10.1902/jop.2007.060217" @default.
• W2143149098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29539193" @default.
• W2143149098 hasPublicationYear "2007" @default.
• W2143149098 type Work @default.
• W2143149098 sameAs 2143149098 @default.
• W2143149098 citedByCount "24" @default.
• W2143149098 countsByYear W21431490982012 @default.
• W2143149098 countsByYear W21431490982013 @default.
• W2143149098 countsByYear W21431490982014 @default.
• W2143149098 countsByYear W21431490982015 @default.
• W2143149098 countsByYear W21431490982016 @default.
• W2143149098 countsByYear W21431490982017 @default.
• W2143149098 countsByYear W21431490982018 @default.
• W2143149098 countsByYear W21431490982020 @default.
• W2143149098 countsByYear W21431490982023 @default.
• W2143149098 crossrefType "journal-article" @default.
• W2143149098 hasAuthorship W2143149098A5005082406 @default.
• W2143149098 hasAuthorship W2143149098A5026127979 @default.
• W2143149098 hasAuthorship W2143149098A5029565955 @default.
• W2143149098 hasAuthorship W2143149098A5030424347 @default.
• W2143149098 hasAuthorship W2143149098A5030839291 @default.
• W2143149098 hasAuthorship W2143149098A5083361918 @default.
• W2143149098 hasConcept C126322002 @default.
• W2143149098 hasConcept C142724271 @default.
• W2143149098 hasConcept C199343813 @default.
• W2143149098 hasConcept C204787440 @default.
• W2143149098 hasConcept C27081682 @default.
• W2143149098 hasConcept C2776151105 @default.
• W2143149098 hasConcept C2777352226 @default.
• W2143149098 hasConcept C2779337755 @default.
• W2143149098 hasConcept C2779416262 @default.
• W2143149098 hasConcept C2780385504 @default.
• W2143149098 hasConcept C2780829032 @default.
• W2143149098 hasConcept C2781413609 @default.
• W2143149098 hasConcept C71924100 @default.
• W2143149098 hasConcept C90924648 @default.
• W2143149098 hasConceptScore W2143149098C126322002 @default.
• W2143149098 hasConceptScore W2143149098C142724271 @default.
• W2143149098 hasConceptScore W2143149098C199343813 @default.
• W2143149098 hasConceptScore W2143149098C204787440 @default.
• W2143149098 hasConceptScore W2143149098C27081682 @default.
• W2143149098 hasConceptScore W2143149098C2776151105 @default.
• W2143149098 hasConceptScore W2143149098C2777352226 @default.

• next